PDF icon PDF herunterladen
Facial Plast Surg 2015; 31(01): 055-069
DOI: 10.1055/s-0035-1544944
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Volume Management of the Middle Third-Lower Orbit/Midface

Edward D. Buckingham
1   Director, Buckingham Center for Facial Plastic Surgery, Austin, Texas
,
Robert Glasgold
2   Department of Surgery, Rutgers University-Robert Wood Johnson Medical School, Piscataway, New Jersey
,
Theda Kontis
3   Department of Facial Plastic Surgery, Johns Hopkins Medical Institutions, Facial Plastic Surgicenter, LLC, Baltimore, Maryland
,
Stephen P. Smith Jr.
4   Department of Otolaryngology, The Ohio State University, Columbus, Ohio
,
Yalon Dolev
5   Department of Facial Plastic and Reconstructive Surgery, ENT Specialty Group, Westmount, Canada
,
Rebecca Fitzgerald
6   Department of Dermatology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
,
Samuel M. Lam
7   Willow Bend Wellness Center, Plano, Texas
,
Edwin F. Williams
8   Williams Center for Excellence, Latham, New York
,
Taylor R. Pollei
8   Williams Center for Excellence, Latham, New York
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
12. März 2015 (online)

Auch verfügbar aufMedOne
   Lizenzen und Reprints
Preview

Abstract

This is the second of the three articles discussing volumetric rejuvenation of the face. The previous article, Volume Rejuvenation of the Facial Upper Third, focused on the upper one-third of the face while this article focuses on the middle one-third, primarily the lower eyelid, cheek, and perioral area. Again, the authors (RG, TK, SPS, RF, SL, and EFW) from the upper face article have provided a summary of rejuvenation utilizing a product of which they are considered an expert. Robert Glasgold has provided volumetric analysis of the region as an introduction.

Keywords

facial volume loss - facial volume replacement - facial rejuvenation

Note

Samuel M. Lam declares that he received no compensation from any company for any of his remarks, which in turn are based solely on his own clinical experience. Therefore, these subjective comments that he made are not meant to be dogmatic, objective, or derogatory in any way to any of the manufacturers.